BDBM50318907 TCV-116 Candesartan Blopress candesartancilexetil Amias Atacand Kenzen CHEMBL1014 CANDESARTAN CILEXETIL 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester 2-Ethoxy-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester Parapres
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid(CV-11974) 2-ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid CHEMBL1016 2-Ethoxy-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid BDBM50240609 CV-11974 CANDESARTAN
- Ni, S; Chen, X; Yu, Q; Xu, Y; Hu, Z; Zhang, J; Zhang, W; Li, B; Yang, X; Mao, F; Huang, J; Sun, Y; Li, J; Jia, L Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth. Eur J Med Chem 185: (2020)